An official website of the United States government
Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina
ORIGINAL RESEARCH — Volume 14 — February 23, 2017
PEER REVIEWED
Figure. Cost-effectiveness efficiency frontier presenting the additional life-years up to date with recommended colorectal cancer screening among the population age-eligible for screening during the intervention window (x -axis) and intervention cost (y -axis) under each of 4 intervention scenarios, compared with screening as usual (existing screening). Results are presented for each intervention alone and for combination scenarios in which interventions are added, one at a time, based on their estimated intervention cost per additional life-year up to date (in 2014 US dollars). The dashed line indicates single and combined intervention scenarios that are not dominated by other intervention scenarios, where “dominated” means that the scenario is both more expensive and has less impact. Dollar values inside the figure indicate cost of each additional life-year up to date.
| Intervention | Intervention Cost | Life-Years Up To Date | Cost of Each Additional Life-Year Up to Date, $ |
|---|---|---|---|
| Screening as usual | 0 | 0 | 0 |
| Endoscopy expansion | 3,000,000.00 | 14,094 | 212.9 |
| Voucher for uninsured | 3,750,000.00 | 41,709 | 89.9 |
| Mailed reminder | 1,619,578.00 | 111,516 | 14.5 |
| Mass media | 3,694,800.00 | 145,821 | 25.3 |
| Mailed reminder + mass media | 5,302,918.00 | 257,306 | 20.6 |
| Mailed reminder + mass media + voucher | 9,049,371.00 | 298,692 | 30.3 |
| All interventions | 12,049,517.00 | 312,648 | 38.5 |
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.